US4968509A
(en)
*
|
1987-07-27 |
1990-11-06 |
Mcneilab, Inc. |
Oral sustained release acetaminophen formulation and process
|
US5073380A
(en)
*
|
1987-07-27 |
1991-12-17 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
US5004613A
(en)
*
|
1987-07-27 |
1991-04-02 |
Mcneil-Ppc, Inc. |
Oral sustained release pharmaceutical formulation and process
|
US5085865A
(en)
*
|
1989-04-12 |
1992-02-04 |
Warner-Lambert Company |
Sustained release pharmaceutical preparations containing an analgesic and a decongestant
|
NZ233403A
(en)
|
1989-04-28 |
1992-09-25 |
Mcneil Ppc Inc |
Simulated capsule-like medicament
|
US5130140A
(en)
*
|
1989-09-14 |
1992-07-14 |
Hoeschst-Roussel Pharmaceuticals Inc. |
Method of making direct dry compressible acetaminophen composition
|
US5198228A
(en)
*
|
1989-09-14 |
1993-03-30 |
Hoechst-Roussel Pharmaceuticals Inc. |
Direct dry compressible acetaminophen tablet
|
US5037658A
(en)
*
|
1989-09-14 |
1991-08-06 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Direct dry compressible acetaminophen composition
|
JPH0714872B2
(ja)
*
|
1990-02-06 |
1995-02-22 |
昭和薬品化工株式会社 |
シロップ剤組成物
|
US5643591A
(en)
*
|
1991-01-16 |
1997-07-01 |
Fmc Corporation |
Solid dosage forms
|
FR2677886B1
(fr)
*
|
1991-06-18 |
1995-03-31 |
Adir |
Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
|
US5141961A
(en)
*
|
1991-06-27 |
1992-08-25 |
Richrdson-Vicks Inc. |
Process for solubilizing difficulty soluble pharmaceutical actives
|
US5225201A
(en)
*
|
1991-08-23 |
1993-07-06 |
Minnesota Mining And Manufacturing Company |
Salsalate tablet
|
US5431916A
(en)
*
|
1993-04-29 |
1995-07-11 |
The Procter & Gamble Company |
Pharmaceutical compositions and process of manufacture thereof
|
US5370878A
(en)
*
|
1993-09-30 |
1994-12-06 |
Hallmark Pharmaceuticals, Inc. |
Method for preparing a direct compression granulated acetaminophen composition
|
US6210714B1
(en)
*
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
US6471994B1
(en)
|
1995-01-09 |
2002-10-29 |
Edward Mendell Co., Inc. |
Pharmaceutical excipient having improved compressibility
|
US5585115A
(en)
*
|
1995-01-09 |
1996-12-17 |
Edward H. Mendell Co., Inc. |
Pharmaceutical excipient having improved compressability
|
US6936277B2
(en)
|
1995-01-09 |
2005-08-30 |
J. Rettenmaier & Soehne Gmbh & Co. Kg |
Pharmaceutical excipient having improved compressibility
|
US6395303B1
(en)
|
1996-06-10 |
2002-05-28 |
Edward Mendell Co., Inc. |
Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
|
US5948438A
(en)
*
|
1995-01-09 |
1999-09-07 |
Edward Mendell Co., Inc. |
Pharmaceutical formulations having improved disintegration and/or absorptivity
|
CR5278A
(es)
*
|
1995-03-24 |
1996-07-04 |
Lilly Co Eli |
Formulacion oral de 2-metil-tieno-benzodiacepina
|
US6391337B2
(en)
|
1995-11-15 |
2002-05-21 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US6852336B2
(en)
|
1995-11-15 |
2005-02-08 |
J. Rettenmaier & Soehne Gmbh + Co. Kg |
Directly compressible high load acetaminophen formulations
|
US5733578A
(en)
|
1995-11-15 |
1998-03-31 |
Edward Mendell Co., Inc. |
Directly compressible high load acetaminophen formulations
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
US5766623A
(en)
*
|
1996-03-25 |
1998-06-16 |
State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University |
Compactable self-sealing drug delivery agents
|
CZ98899A3
(cs)
*
|
1996-09-24 |
1999-12-15 |
Eli Lilly And Company |
Složení potahovaných částic
|
US7179486B1
(en)
|
1997-04-01 |
2007-02-20 |
Nostrum Pharmaceuticals, Inc. |
Process for preparing sustained release tablets
|
US8524277B2
(en)
*
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US6254891B1
(en)
|
1998-09-03 |
2001-07-03 |
Ascent Pediatrics, Inc. |
Extended release acetaminophen
|
US6126967A
(en)
*
|
1998-09-03 |
2000-10-03 |
Ascent Pediatrics |
Extended release acetaminophen particles
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6432448B1
(en)
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6245913B1
(en)
|
1999-06-30 |
2001-06-12 |
Wockhardt Europe Limited |
Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
|
US6264983B1
(en)
|
1999-09-16 |
2001-07-24 |
Rhodia, Inc. |
Directly compressible, ultra fine acetaminophen compositions and process for producing same
|
US6500462B1
(en)
|
1999-10-29 |
2002-12-31 |
Fmc Corporation |
Edible MCC/PGA coating composition
|
GB0009522D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Smithkline Beecham Plc |
Composition
|
US6358526B1
(en)
|
2000-08-16 |
2002-03-19 |
Rexall Sundown |
Method of making tablets and tablet compositions produced therefrom
|
SE0003125D0
(sv)
*
|
2000-09-05 |
2000-09-05 |
Astrazeneca Ab |
Modified polymers
|
BR0115585A
(pt)
|
2000-11-28 |
2005-12-13 |
Fmc Corp |
Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
|
KR100392430B1
(ko)
*
|
2001-02-01 |
2003-07-23 |
부광약품 주식회사 |
속효성과 지속성을 동시에 갖는 발포성 아세트아미노펜제제
|
US6602911B2
(en)
*
|
2001-11-05 |
2003-08-05 |
Cypress Bioscience, Inc. |
Methods of treating fibromyalgia
|
PT1485078E
(pt)
*
|
2002-03-15 |
2013-01-14 |
Cypress Bioscience Inc |
Milnacipran para o tratamento do síndrome do intestino irritável
|
KR100522239B1
(ko)
*
|
2002-07-16 |
2005-10-18 |
주식회사 서울제약 |
아세트아미노펜을 함유하는 제어방출성의 경구용 제제
|
WO2004026308A1
(fr)
*
|
2002-09-21 |
2004-04-01 |
Shuyi Zhang |
Compose d'acetamidophenol et de tramadol a liberation prolongee
|
US20090162431A1
(en)
*
|
2002-09-21 |
2009-06-25 |
Shuyi Zhang |
Sustained release formulations containing acetaminophen and tramadol
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
JP2006515008A
(ja)
*
|
2003-01-28 |
2006-05-18 |
コレギウム ファーマシューティカル, インコーポレイテッド |
経口投与のためのミルナシプランの多粒子状組成物
|
DE602004032149D1
(de)
*
|
2003-09-26 |
2011-05-19 |
Alza Corp |
Oros-push-stick für die kontrollierte abgabe von wirkstoffen
|
ATE544447T1
(de)
|
2003-09-26 |
2012-02-15 |
Alza Corp |
Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
|
AU2004275835B2
(en)
*
|
2003-09-26 |
2011-06-23 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
US7897172B2
(en)
*
|
2004-05-18 |
2011-03-01 |
L. Perrigo Company |
Tablets exhibiting reduced drug release variability
|
US20060018837A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Victory Pharma, Inc. |
Pharmaceutical compositions and methods for the prevention of drug misuse
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
CA2616416A1
(en)
*
|
2005-09-09 |
2007-05-03 |
Labopharm, Inc. |
Trazodone composition for once a day adminisitiation
|
US7994220B2
(en)
|
2005-09-28 |
2011-08-09 |
Cypress Bioscience, Inc. |
Milnacipran for the long-term treatment of fibromyalgia syndrome
|
GB0525461D0
(en)
|
2005-12-15 |
2006-01-25 |
Archimedes Dev Ltd |
Pharmaceutical compositions
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
KR100762847B1
(ko)
*
|
2006-01-27 |
2007-10-04 |
씨제이 주식회사 |
멀티플 유닛 타입 서방성 경구 제제 및 그 제조방법
|
KR100753480B1
(ko)
*
|
2006-01-27 |
2007-08-31 |
씨제이 주식회사 |
잘토프로펜 함유 서방성 정제 및 그 제조방법
|
US20080057122A1
(en)
*
|
2006-08-31 |
2008-03-06 |
Aaipharma Inc. |
Acetaminophen pharmaceutical compositions
|
US8653066B2
(en)
|
2006-10-09 |
2014-02-18 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
US9078824B2
(en)
*
|
2007-09-24 |
2015-07-14 |
The Procter & Gamble Company |
Composition and method of stabilized sensitive ingredient
|
ES2541809T3
(es)
*
|
2007-10-16 |
2015-07-24 |
Paladin Labs Inc. |
Composición bicapa para la liberación sostenida de acetaminofeno y tramadol
|
RU2010129907A
(ru)
|
2007-12-17 |
2012-01-27 |
Лабофарм Инк. (CA) |
Лекарственная форма с контролируемым высвобождением, предотвращающая неправильное употребление
|
US8124126B2
(en)
|
2008-01-09 |
2012-02-28 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
US8372432B2
(en)
|
2008-03-11 |
2013-02-12 |
Depomed, Inc. |
Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
|
JP5607550B2
(ja)
|
2008-03-11 |
2014-10-15 |
ディポメド,インコーポレイティド |
非オピオイド鎮痛剤及びオピオイド鎮痛剤の組合せを含む胃保持性持続放出剤形
|
BRPI0917206B1
(pt)
*
|
2008-07-31 |
2018-04-17 |
Clarke Mosquito Control Products, Inc. |
Método para a formação de uma pastilha comprimida de liberação dupla, pastilhas comprimidas e método para a fabricação de uma matriz sólida de liberação prolongada
|
ES2509497T3
(es)
|
2008-12-16 |
2014-10-17 |
Paladin Labs Inc. |
Formulación de liberación controlada para evitar un uso indebido
|
EP3311667A1
(de)
|
2009-07-08 |
2018-04-25 |
Charleston Laboratories, Inc. |
Pharmazeutische zusammensetzungen
|
BR112012004525A2
(pt)
*
|
2009-08-31 |
2016-03-22 |
Depomed Inc |
composição farmacêuticas gástrico-rententivas para liberação imediata ou prolongada de acetaminofeno
|
CN102548544B
(zh)
|
2009-10-09 |
2015-01-21 |
永进药品工业株式会社 |
同时具有速效特性和长效特性的药物组合物
|
SG194605A1
(en)
*
|
2011-05-06 |
2013-12-30 |
Glaxosmithkline Llc |
Sustained release paracetamol formulations
|
AU2012326976B2
(en)
|
2011-10-21 |
2017-08-17 |
Takeda Pharmaceutical Company Limited |
Sustained-release preparation
|
WO2016042570A1
(en)
*
|
2014-09-16 |
2016-03-24 |
Suresh Pareek |
Extended release formulation of acetaminophen
|
CA2902911C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
WO2017152130A1
(en)
|
2016-03-04 |
2017-09-08 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|